Antihypertensive treatment with beta-blockers in the metabolic syndrome: a review
AM Carella, G Antonucci, M Conte… - Current Diabetes …, 2010 - ingentaconnect.com
Metabolic syndrome, a “cluster” of metabolic disorders including hypertension, increases the
cardiovascular risk, and insulin resistance plays a key role in its pathogenesis. In this …
cardiovascular risk, and insulin resistance plays a key role in its pathogenesis. In this …
[PDF][PDF] Antihypertensive Treatment with Beta-Blockers in the Metabolic Syndrome: A Review
AM Carella, G Antonucci, M Conte… - Current Diabetes …, 2010 - academia.edu
Metabolic syndrome, a “cluster” of metabolic disorders including hypertension, increases the
cardiovascular risk, and insulin resistance plays a key role in its pathogenesis. In this …
cardiovascular risk, and insulin resistance plays a key role in its pathogenesis. In this …
Antihypertensive treatment with beta-blockers in the metabolic syndrome: a review
AM Carella, G Antonucci, M Conte… - Current diabetes …, 2010 - pubmed.ncbi.nlm.nih.gov
Metabolic syndrome, a" cluster" of metabolic disorders including hypertension, increases the
cardiovascular risk, and insulin resistance plays a key role in its pathogenesis. In this …
cardiovascular risk, and insulin resistance plays a key role in its pathogenesis. In this …
Antihypertensive treatment with beta-blockers in the metabolic syndrome: a review.
AM Carella, G Antonucci, M Conte… - Current Diabetes …, 2010 - europepmc.org
Metabolic syndrome, a" cluster" of metabolic disorders including hypertension, increases the
cardiovascular risk, and insulin resistance plays a key role in its pathogenesis. In this …
cardiovascular risk, and insulin resistance plays a key role in its pathogenesis. In this …
[PDF][PDF] Antihypertensive Treatment with Beta-Blockers in the Metabolic Syndrome: A Review
AM Carella, G Antonucci, M Conte… - Current Diabetes …, 2010 - researchgate.net
Metabolic syndrome, a “cluster” of metabolic disorders including hypertension, increases the
cardiovascular risk, and insulin resistance plays a key role in its pathogenesis. In this …
cardiovascular risk, and insulin resistance plays a key role in its pathogenesis. In this …
Antihypertensive treatment with beta-blockers in the metabolic syndrome: a review
AM Carella, G Antonucci, M Conte… - Current Diabetes …, 2010 - hero.epa.gov
Metabolic syndrome, a" cluster" of metabolic disorders including hypertension, increases the
cardiovascular risk, and insulin resistance plays a key role in its pathogenesis. In this …
cardiovascular risk, and insulin resistance plays a key role in its pathogenesis. In this …